Barr Ellison Solicitors – commercial property
Advertisement: Mogrify mid banner
Advertisement: Cambridge Network
RealVNC mid banner careers
ARM Innovation Hub
RealVNC mid-banner general
Advertisement: Bradfield Centre mid
Advertisement Cambridge China Centre
Advertisement EY mid banner
Advertisement: RSM
Advertisement: Wild Knight Vodka
Advertisement: TTP
Mid banner advertisement: BDO
5 March, 2014 - 11:38 By News Desk

Cardiovascular R & D platform for preclinical drug development

heart

A privately owned Hungarian SME is offering innovative and cost-effective preclinical R & D services focusing on cardiovascular diseases (e.g. infarction, heart failure, arrhythmias, sepsis) efficacy, safety, and pharmacokinetic animal models, including co-morbidity, custom designed and large animal models as well.

The company is looking for partners that are interested in out-sourcing their preclinical pharmacology projects. The company is open for joint venture or technical cooperation.

Closing date: 22/01/2015

Ref: TOHU20131210001

Add new comment

Newsletter Subscription

Stay informed of the latest news and features